Pragati: AI for Impact Convening by Meta and The/Nudge Institute advances India’s Inclusive AI Agenda
- The 'Pragati: AI for Impact' convening saw the participation of 150+…
Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical…
Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer’s Disease
TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the…
MEXC Unveils New Launchpad Featuring BTC to Kick Off BTC Trading Month
VICTORIA, Seychelles, June 9, 2025 /PRNewswire/ -- In a bold move to…
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease…